GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Goodbody Health Ltd (OTCPK:GDBYF) » Definitions » 3-Year RORE %

Goodbody Health (Goodbody Health) 3-Year RORE % : 0.00% (As of Sep. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Goodbody Health 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Goodbody Health's 3-Year RORE % for the quarter that ended in Sep. 2022 was 0.00%.

The industry rank for Goodbody Health's 3-Year RORE % or its related term are showing as below:

GDBYF's 3-Year RORE % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.545
* Ranked among companies with meaningful 3-Year RORE % only.

Goodbody Health 3-Year RORE % Historical Data

The historical data trend for Goodbody Health's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goodbody Health 3-Year RORE % Chart

Goodbody Health Annual Data
Trend Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Dec21
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.67 -18.34 76.42 38.84 -

Goodbody Health Quarterly Data
Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Goodbody Health's 3-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Goodbody Health's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Goodbody Health's 3-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Goodbody Health's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Goodbody Health's 3-Year RORE % falls into.



Goodbody Health 3-Year RORE % Calculation

Goodbody Health's 3-Year RORE % for the quarter that ended in Sep. 2022 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( - )/( -2.455-0 )
=/-2.455
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2022 and 3-year before.


Goodbody Health  (OTCPK:GDBYF) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Goodbody Health 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Goodbody Health's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Goodbody Health (Goodbody Health) Business Description

Traded in Other Exchanges
N/A
Address
Stubbs Lane, Beckington Frome, The Blue Building, Somerset, GBR, BA11 6TE
Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.